Mary Blake Sheahan
Director/Board Member at Janssen Alzheimer Immunotherapy
Profile
Mary Blake Sheahan is currently a Non-Executive Director at Venn Life Sciences Ltd.
and a Director at Janssen Alzheimer Immunotherapy.
She previously worked as an Independent Non-Executive Director at Venn Life Sciences Holdings Plc, and as the Head of Human Resources & Information Technology at Elan Corp.
Plc from 1997 to 2014.
She also worked as a Senior Vice President-Global Integration at Perrigo Co. Plc.
Ms. Sheahan received her undergraduate and graduate degrees from University College Dublin.
Mary Blake Sheahan active positions
Companies | Position | Start |
---|---|---|
Janssen Alzheimer Immunotherapy | Director/Board Member | - |
Venn Life Sciences Ltd.
Venn Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Venn Life Sciences Ltd. provides clinical research services. It offers drug development planning and strategy, early drug development, clinical trials, and support services. The company was founded in 2007 and is headquartered in County Dublin, Ireland. | Director/Board Member | - |
Former positions of Mary Blake Sheahan
Companies | Position | End |
---|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | 2014-04-23 |
PERRIGO COMPANY PLC | Corporate Officer/Principal | - |
Venn Life Sciences Holdings Plc
Venn Life Sciences Holdings Plc Services to the Health IndustryHealth Services Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland. | Director/Board Member | - |
Training of Mary Blake Sheahan
University College Dublin | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PERRIGO COMPANY PLC | Health Technology |
Private companies | 4 |
---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Venn Life Sciences Ltd.
Venn Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Venn Life Sciences Ltd. provides clinical research services. It offers drug development planning and strategy, early drug development, clinical trials, and support services. The company was founded in 2007 and is headquartered in County Dublin, Ireland. | Commercial Services |
Janssen Alzheimer Immunotherapy | |
Venn Life Sciences Holdings Plc
Venn Life Sciences Holdings Plc Services to the Health IndustryHealth Services Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland. | Health Services |
- Stock Market
- Insiders
- Mary Blake Sheahan